Fig. 5

VC-hAECs elevated CTX-damaged hGC marker expression more powerfully than hAECs. a, b FACS results showing the percent of FSHR⁺AMH⁺ cells and FOXL2⁺CYP19A1⁺ cells in CTX-damaged hGCs after coculturing with hAECs and VC-hAECs. c Protein level analysis of hGC marker (FSHR, AMH, FOXL2, CYP19A1) expression in CTX-damaged hGCs after coculturing with hAECs and VC-hAECs. One-way ANOVA was performed followed by Scheffe’s t test, *p < 0.05, versus hAECs/POI group. NG = normal group with PBS-treated normal hGCs, POI = CTX-damaged hGCs, hAECs/POI = CTX-damaged hGCs cocultured with hAECs, VC-hAECs/POI = CTX-damaged hGCs cocultured with VC-treated hAECs